PERKINS CAPITAL MANAGEMENT INC – NeuBase Therapeutics, Inc. Transaction History
PERKINS CAPITAL MANAGEMENT INC portfolio value:
$39,000
portfolio value
PERKINS CAPITAL MANAGEMENT INC quarter portfolio value change:
-62.38%
quarter
NeuBase Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +20.25% | 16.5K shares | -47K | $0.4 | 98K |
| Q2 2022 | share | Increase | +22.56% | 15K shares | -39K | $1.05 | 81.5K |
| Q1 2022 | share | Increase | +121.67% | 36.5K shares | 41K | $1.88 | 66.5K |
| Q4 2021 | share | Increase | +42.86% | 9K shares | 8K | $2.64 | 30K |
| Q3 2021 | share | Increase | +41.89% | 6.2K shares | 5K | $3.61 | 21K |
| Q2 2021 | share | Increase | 0.00% | 14.8K shares | 71K | $4.79 | 14.8K |